Sleep apnoea and hypertension: Time for recommendations

European Respiratory Journal

Volumn 41, Issue 3, 2013, Pages 505-506

  Lévy, Patrick ^a   McNicholas, Walter T ^b  

^a UNIV GRENOBLE ALPES   (France)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPOXIA; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SYMPATHETIC TONE; VASOCONSTRICTION;

FEMALE; HUMANS; HYPERTENSION; MALE; SLEEP APNEA, OBSTRUCTIVE;

EID: 84875252855     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00007213     Document Type: Editorial

References (28)

1. Baguet JP, Narkiewicz K, Mallion JM. Update on hypertension management: Obstructive sleep apnea and hypertension. J Hypertens 2006; 24: 205-208.
2. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 Report. JAMA 2003; 289: 2560-2572.
3. McNicholas WT, Bonsignore MR, COST action B26 MC. Sleep apnoea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-178.
4. Baguet JP, Barone-Rochette G, Tamisier R, et al. Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol 2012; 9: 679-688.
5. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large communitybased study. Sleep heart health study. JAMA 2000; 283: 1829-1836.
6. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
7. Baguet JP, Hammer L, Levy P, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005; 23: 521-527.
8. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012; 307: 2169-2176.
9. Baguet JP, Levy P, Barone-Rochette G, et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008; 26: 885-892.
10. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19: 2271-2277.
11. Grote L, Hedner J, Peter JH. Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder. J Hypertens 2001; 19: 683-690.
12. Levy P, Tamisier R, Arnaud C, et al. Sleep deprivation, sleep apnea and cardiovascular diseases. Front Biosci (Elite Ed) 2012; 4: 2007-2021.
13. Brooks D, Horner RL, Kimoff RJ, et al. Effect of obstructive sleep apnea versus sleep fragmentation on responses to airway occlusion. Am J Respir Crit Care Med 1997; 155: 1609-1617.
14. Tamisier R, Gilmartin GS, Launois SH, et al. A new model of chronic intermittent hypoxia in humans: Effect on ventilation, sleep, and blood pressure. J Appl Physiol 2009; 107: 17-24.
15. Tamisier R, Pepin JL, Remy J, et al. Fourteen nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J 2011; 37: 119-128.
16. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised parallel trial. Lancet 2002; 359: 204-210.
17. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.
18. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: Evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167: 757-764.
19. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: A randomized, controlled trial. Ann Intern Med 2001; 134: 1015-1023.
20. Robinson GV, Smith DM, Langford BA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006; 27: 1229-1235.
21. Barbe F, Duran-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718-726.
22. Pepin JL, Tamisier R, Barone-Rochette G, et al. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 182: 954-960.
23. Barbe F, Duran-Cantolla J, Carmona C, et al. Effect of CPAP treatment on the incidence of cardiovascular events and hypertension in non-sleepy OSAS patients. A long-term RCT. Am J Respir Crit Care Med 2010; 181: A5559.
24. Parati G, Lombardi C, Hedner J, et al. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 2013; 41: 523-538.
25. Parati G, Lombardi C, Hedner J, et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: Joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (Cooperation in Scientific and Technological Research) Action B26 on obstructive sleep apnea. J Hypertens 2012; 30: 633-646.
26. Fietze I, Penzel T, Alonderis A, et al. Management of obstructive sleep apnea in Europe. Sleep Med 2011; 12: 190-197.
27. Alonderis A, Barbe F, Bonsignore M, et al. Medico-legal implications of sleep apnoea syndrome: Driving license regulations in Europe. Sleep Med 2008; 9: 362-375.
28. Rodenstein D, Cost-B26 Action on Sleep Apnoea Syndrome. Driving in Europe: The need of a common policy for drivers with obstructive sleep apnoea syndrome. J Sleep Res 2008; 17: 281-284.